SGLT-2 inhibitors and GLP-1 receptor agonists were associated with a reduced risk of moderate or severe COPD exacerbations compared with DPP-4 inhibitors in adults with type 2 diabetes.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
"Medicare beneficiaries who undergo EBV present with fewer comorbidities, but after risk adjustment they have higher mortality and procedure-related morbidity than those undergoing LVRS," finds study of 3,219 patients comparing contemporary surgical outcomes.
New research demonstrates cardiovascular health metrics inversely correlate with COPD risk, with high LE8 scores associated with 82% lower disease prevalence in adults older than age 40.
Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.
A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.